Cargando…

Metformin serum concentrations during pregnancy and post partum – A clinical study in patients with polycystic ovary syndrome

BACKGROUND AND OBJECTIVES: Metformin is used to treat gestational diabetes. It is also used to treat women with polycystic ovary syndrome and has been shown to prevent late miscarriage and preterm birth. However, increased renal clearance during pregnancy causes a decline in serum concentrations of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espnes, Ketil Arne, Hønnås, Arne, Løvvik, Tone S., Gundersen, Per Ole M., Naavik, Audhild, Skogvoll, Eirik, Westin, Andreas A., Spigset, Olav, Vanky, Eszter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304251/ https://www.ncbi.nlm.nih.gov/pubmed/34964262 http://dx.doi.org/10.1111/bcpt.13703

Ejemplares similares

FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
por: Husby, Anne Engtrø, et al.
Publicado: (2023)

Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
por: Trouva, Anastasia, et al.
Publicado: (2022)

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
por: Gjestad, Caroline, et al.
Publicado: (2015)

Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome
por: Stokkeland, Live Marie T, et al.
Publicado: (2021)

HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome
por: Odsæter, Ingrid Hov, et al.
Publicado: (2015)

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2017)

Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition
por: Westin, Andreas A., et al.
Publicado: (2017)

Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway
por: Westin, Andreas Austgulen, et al.
Publicado: (2017)

Academic detailing as a method of continuing medical education
por: Dyrkorn, Roar, et al.
Publicado: (2019)

Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS
por: Ryssdal, Mariell, et al.
Publicado: (2023)

Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study
por: Grindheim, Sindre, et al.
Publicado: (2022)

No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
por: Fougner, Stine Lyngvi, et al.
Publicado: (2021)

Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials
por: Ujvari, Dorina, et al.
Publicado: (2023)

Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome
por: Kiel, Ida Almenning, et al.
Publicado: (2022)

Polycystic ovary syndrome and extremely preterm birth: A nationwide register-based study
por: Valgeirsdottir, Heiddis, et al.
Publicado: (2021)

Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Study
por: Almenning, Ida, et al.
Publicado: (2015)

Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC–QTOF–MS
por: Gundersen, Per Ole M., et al.
Publicado: (2018)

Serum Concentrations of Paliperidone After Administration of the Long-Acting Injectable Formulation
por: Helland, Arne, et al.
Publicado: (2017)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

Circulating and Adipose Tissue miRNAs in Women With Polycystic Ovary Syndrome and Responses to High-Intensity Interval Training
por: Lionett, Sofie, et al.
Publicado: (2020)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

A Review of First Line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome
por: Costello, Michael, et al.
Publicado: (2019)

Stability of 21 Antihypertensive Drugs in Serum Collected in Standard (Nongel) Serum Tubes Versus Tubes Containing a Gel Separator
por: Hegstad, Solfrid, et al.
Publicado: (2020)

Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis
por: Mousa, Aya, et al.
Publicado: (2020)

Peer academic detailing on use of antibiotics in acute respiratory tract infections. A controlled study in an urban Norwegian out-of-hours service
por: Dyrkorn, Roar, et al.
Publicado: (2016)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome
por: Zhang, Yuehui, et al.
Publicado: (2017)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

A Review of Second- and Third-line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome
por: Costello, Michael F., et al.
Publicado: (2019)

Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe
por: Piltonen, Terhi T., et al.
Publicado: (2019)

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
por: Tan, Bee K., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0iqus1ptj88dp9cn8dj7obfb6m